SK bioscience, Hilleman to develop second-generation Zaire Ebola virus vaccine
Under the partnership, both firms will develop an improved Zaire Ebola virus vaccine candidate and enhance product thermostability…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
23 Nov 23
Under the partnership, both firms will develop an improved Zaire Ebola virus vaccine candidate and enhance product thermostability…
23 Nov 23
The company has designed an AI stack to detect new therapeutic targets and forecast responses of patients to…
23 Nov 23
The next-generation ROS1 tyrosine kinase inhibitor (TKI) is intended for use in adult patients dealing with locally advanced…
23 Nov 23
By leveraging WuXiUP, WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing from perfused cell…
22 Nov 23
The US-based biotechnology company will receive an upfront payment and is eligible for additional payments totalling up to…
22 Nov 23
The partnership is intended to improve Genentech's advanced AI research programmes by converting its generative AI models and…
22 Nov 23
Under the agreement, Merck will acquire all the outstanding shares of Massachusetts-based Caraway with earnout milestones related to…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
22 Nov 23
With the completion of the second phase, Merck now offers a comprehensive range of biosafety testing services for…
22 Nov 23
Next-generation propellant technology has the potential to reduce greenhouse gas emissions from Ventolin (salbutamol) inhaler by approximately 90%
22 Nov 23
Myricx intends to progress the ADC through preclinical and clinical development for difficult-to-treat solid tumours